Showing results (661-670 of 718) with videos related to

Sort By:
Pageof 72
The Lancet. Microbe|May 11, 2022
Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysisMohammadali Yavari Ramsheh, Koirobi Haldar, Anna Esteve-Codina, et al.
The Lancet. Respiratory Medicine|April 2, 2021
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trialJürgen Behr, Antje Prasse, Michael Kreuter, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 25, 2020
Immunoglobulin deficiency as an indicator of disease severity in patients with COVID-19Faeq Husain-Syed, István Vadász, Jochen Wilhelm, et al.
Critical Care (London, England)|May 31, 2017
Outcome of acute respiratory distress syndrome in university and non-university hospitals in GermanyKonstantinos Raymondos, Tamme Dirks, Michael Quintel, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Spatial Transcriptomics Uncovers Hybrid, Pro-Inflammatory and Pro-Fibrotic Cellular Niches in Pulmonary Granuloma of Patients with Chronic SarcoidosisLeonard Christian, Hande Yilmaz, Jannik Ruwisch, et al.
Infection|July 6, 2021
Key summary of German national treatment guidance for hospitalized COVID-19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021)Jakob J Malin, Christoph D Spinner, Uwe Janssens, et al.
Nature|July 28, 2022
Impaired ketogenesis ties metabolism to T cell dysfunction in COVID-19Fotios Karagiannis, Konrad Peukert, Laura Surace, et al.
Respiration; International Review of Thoracic Diseases|March 20, 2026
Management of Adult Bronchiectasis - Consensus-based Guidelines of the German Respiratory SocietyFelix C Ringshausen, Ingo Baumann, Andrés de Roux, et al.
JAMA|June 14, 2012
Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trialFrank M Brunkhorst, Michael Oppert, Gernot Marx, et al.
Immunity|February 10, 2021
COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responsesAgnes Bonifacius, Sabine Tischer-Zimmermann, Anna C Dragon, et al.
Pageof 72